Navigation Links
Lou Paradise, President and Chief of Research, Topical BioMedics, Inc. Slated to Speak at Integrative Healthcare Symposium
Date:2/22/2013

Rhinebeck, NY (PRWEB) February 22, 2013

Lou Paradise, pain management expert and president and chief of research of Topical BioMedics, Inc. Rhinebeck, NY, is scheduled to speak at the 2013 Integrative Healthcare Symposium. The IHS takes place at The Hilton New York in Manhattan from February 27th through March 2nd. Keynote speakers include Jeffrey Bland, PhD, FACN, FACB; David Perlmutter, MD, FACN, ABIHM; Larry Dossey, MD, Recipient of 2013 Visionary Award; and Mehmet Oz, MD, Recipient of 2013 Leadership Award.

On Thursday, February 28th from 6:30pm – 7:15pm in the Gibson Suite in the Presentation Hall, Mr. Paradise will be conducting his lecture on “Effective Prevention of Addiction to Opioid Pain Killers. “Addiction to opioid pain killers is being called the defining drug problem of the 21st century,” says Mr. Paradise, “This reality has negatively impacted millions of people and their families from every walk of life in our country. If allowed to continue it will cause far-reaching, irreparable damage to the very fabric of normal life for the average person, and undermine any hope of seeing a health and wellness platform for a sustainable healthcare model.”

Mr. Paradise’s session will explore an effective safe natural pain treatment protocol that provides a viable platform to treat the cause of pain at the cellular level versus just symptom control. “Unresolved pain--a primary reason those in pain abuse oral opioid pain killers--can be successfully treated and addiction can be reversed and prevented when we respect and support the body’s ability to heal itself,” says Mr. Paradise.    

A pain management specialist, Mr. Paradise is a decorated US Marine Corps combat veteran who frequently serves as an expert speaker on the use of natural medicines, conducts pain management seminars, and participates in addressing compliance issues related to regulated natural medicines as a memb
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
2. Elsevier / MEDai Appoints Tom Zajac as New President
3. GenVec President and Chief Executive Officer Announces Retirement
4. Michael A. Marletta Takes Office as New President of Scripps Research Institute
5. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
6. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
7. Neuralstem President and CEO to Update Ongoing ALS and NSI-189/Major Depressive Disorder Trials at 2012 Biotech Showcase
8. Zyga Technology, Inc. Announces the Appointment of Jim Bullock as President and CEO
9. Cepheid Welcomes Senior Vice President of Human Resources
10. Neuralstem President and CEO to Present at BIO CEO & Investor Conference 2012
11. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015 ... announced the addition of the "Global Biosimilars ... offering. The Global Biosimilars Market, 2015 ... the rapidly growing biosimilars market. With the blockbuster ... to minimize costs, biosimilars are being viewed as ...
(Date:7/29/2015)... 2015  AmnioChor Inc., an early stage biotech startup ... to announce that the Musculoskeletal Transplant Foundation of ... in their seed round of development of the proprietary ... AmnioChor,s technology allows cryopreservation of the ... cells living within those tissues. Amnion is a well-established ...
(Date:7/29/2015)... 2015  Pfenex Inc. (NYSE MKT: PFNX) announced today ... released on Thursday, August 13, 2015, before the open ... will host a conference call to discuss the financial ... outlining the financial results and business update will be ... call 1-866-376-8058 (US) or 1-412-542-4131 (international) and reference Pfenex ...
(Date:7/29/2015)... ... July 29, 2015 , ... The third Medical Innovation Impact Index (MI3) ... in particular, drug/device combinations. The current system received a score of 0 (range -10 ... Centered Innovation (iPCI) of Fairleigh Dickinson University’s ( FDU ) Rothman Institute of ...
Breaking Biology Technology:Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3
... May 5, 2011 Advanced Life Sciences Holdings, ... the discovery, development and commercialization of novel drugs in ... announced today that it has suspended operations and terminated ...   (Logo:   http://photos.prnewswire.com/prnh/20080218/ALSLOGO ) ...
... Codexis, Inc. (NASDAQ: CDXS ) today announced ...   First Quarter Financial Highlights:Revenue: For the ... million, an increase of 21% from $25.7 million in the ... 106% over the same time period driven by more than ...
... CARLOS, Calif., May 5, 2011 PharmacoFore, Inc., a ... announced today that it is a sponsor of the ... Meeting, scheduled for November 29, 2011 in Washington, DC. ... CEO of PharmacoFore, Inc., stated, "PharmacoFore shares CLAAD,s objective ...
Cached Biology Technology:Advanced Life Sciences Suspends Operations 2Codexis Reports First Quarter 2011 Results 2Codexis Reports First Quarter 2011 Results 3Codexis Reports First Quarter 2011 Results 4Codexis Reports First Quarter 2011 Results 5Codexis Reports First Quarter 2011 Results 6Codexis Reports First Quarter 2011 Results 7PharmacoFore, Inc. Announces Sponsorship of the 2011 CLAAD National Prescription Drug Abuse Prevention Policy Consensus Meeting on November 29, 2011 in Washington, DC 2PharmacoFore, Inc. Announces Sponsorship of the 2011 CLAAD National Prescription Drug Abuse Prevention Policy Consensus Meeting on November 29, 2011 in Washington, DC 3
(Date:7/21/2015)... Today, ZTE announced its Android smartphone Axon, ... expected revenues in 2015 that relate to sales of FPC1025 for ... approximately 2,200 MSEK for 2015. Jörgen Lantto, CEO of ... in China and we are proud that ... for Axon , its first ...
(Date:7/21/2015)... 2015 Passwords have proven futile for ... recent U.S. Office of Personnel Management breach. Biometric ... conundrum, but developers and end-users are concerned about ... dilemma, Biometrics-as-a-Service provider HYPR Corp. announced today the ... third party integration. A video ...
(Date:7/13/2015)... , July 13, 2015 Synaptics Inc. ... human interface solutions, today announced sampling of ClearPad ... display driver integration (TDDI) product targeting smartphones and ... to combine Synaptics , best-in-class touch controller ... driver technology developed in the company,s Japan Design ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3
... Earth,s paleoclimate history by NASA,s Goddard Institute for Space ... rapid climate changes this century, including multiple meters of ... By looking at how the Earth,s climate responded ... fundamental question raised by ongoing human-caused climate change: "What ...
... of bees and brains made up of neurons make decisions ... Dec. 9 issue of Science . In previous ... in a honeybee swarm perform "waggle dances" to prompt other ... found. In the new study, Seeley, a professor ...
... economy (HE), in which hydrogen would replace the carbon-based fossil ... 1970s. Today, HE is seen as a potential solution to ... reserves. A research paper to be published in the ... wrong and SHE has the answer in the sustainable hydrogen ...
Cached Biology News:Paleoclimate record points toward potential rapid climate changes 2Paleoclimate record points toward potential rapid climate changes 3Paleoclimate record points toward potential rapid climate changes 4Building a sustainable hydrogen economy 2
Request Info...
... Recognizes Kir2.1 protein. The epitope ... not present in any other known ... is identical in rabbit, bovine, porcine ... homologous in rat and mouse (17/19 ...
Anti-20S proteasome subunits alpha 1, 2, 3, 5, 6 & 7, clone MCP231 Immunogen: Dinitrophenylated proteasomes Molecular Weight: 29 and 32 kDa....
Tight junctions are complexes of proteins that create intercellular boundaries between the plasma membrane domains of epithelial and endothelial cells. Antigen: Synthetic peptide corresponding to...
Biology Products: